Clinical trials
7 active studies led by MedImmune LLC, of 271 in all
Source: ClinicalTrials.gov, Studies with MedImmune LLC (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 4Markets in public records
- 0Regions & countries
- 7Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by MedImmune LLC or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on MedImmune LLC
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- medimmune.com
- Home country
- United States
- Part of
- AstraZeneca
- Type
- Medicines
Source: Wikidata, Company record Q1335294. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies MedImmune LLC leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with MedImmune LLC or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show MedImmune LLC: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets MedImmune LLC is in.
From our blog
Stories on the topics MedImmune LLC works in.
Brain Cancer Diagnosis: Imaging and New Biomarkers
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Wound Care: Advanced Dressings for Faster Healing
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Bioinformatics: Making Sense of Health Data
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read